Trinity Biotech | TRIB - Ordinary Share Capital


Trinity Biotech reported $385.2M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Bayer EUR 982.42M 0 Dec/2025
Bio-Rad Laboratories USD 26.97M 90K Sep/2025
EDAP TMS EUR 37.39M 0 Sep/2025
J&J USD 2.41B 584K Sep/2025
Mesa Laboratories USD 349.53M 3.53M Sep/2024
OraSure Technologies USD 70.39M 1.87M Dec/2025
Plus Therapeutics USD 138.68M 7.07M Dec/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Siemens EUR 780.74M 6.33M Dec/2025
Surmodics USD 14.3M 13.58M Jun/2025
Thermo Fisher Scientific USD 375.71M 1.9M Dec/2025
Tosoh JPY 310.36M 5.45M Dec/2025
Trinity Biotech USD 385.2M 382.82M Jun/2025
Veracyte USD 79.05M 377K Dec/2025